ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA Medicine Based on DNA Modification Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-39O12330
Home | Market Reports | Science| Biological Sciences
Global DNA Medicine Based on DNA Modification Market Research Report 2022
BUY CHAPTERS

Global DNA Medicine Based on DNA Modification Market Research Report 2025

Code: QYRE-Auto-39O12330
Report
February 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute

DNA Medicine Based on DNA Modification Market Size

The global market for DNA Medicine Based on DNA Modification was valued at US$ 13690 million in the year 2024 and is projected to reach a revised size of US$ 48640 million by 2031, growing at a CAGR of 20.2% during the forecast period.

DNA Medicine Based on DNA Modification Market

DNA Medicine Based on DNA Modification Market

Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report aims to provide a comprehensive presentation of the global market for DNA Medicine Based on DNA Modification, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Medicine Based on DNA Modification.
The DNA Medicine Based on DNA Modification market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Medicine Based on DNA Modification market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Medicine Based on DNA Modification companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of DNA Medicine Based on DNA Modification Market Report

Report Metric Details
Report Name DNA Medicine Based on DNA Modification Market
Accounted market size in year US$ 13690 million
Forecasted market size in 2031 US$ 48640 million
CAGR 20.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Viral
  • Non-viral
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of DNA Medicine Based on DNA Modification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is DNA Medicine Based on DNA Modification Market growing?

Ans: The DNA Medicine Based on DNA Modification Market witnessing a CAGR of 20.2% during the forecast period 2025-2031.

What is the DNA Medicine Based on DNA Modification Market size in 2031?

Ans: The DNA Medicine Based on DNA Modification Market size in 2031 will be US$ 48640 million.

Who are the main players in the DNA Medicine Based on DNA Modification Market report?

Ans: The main players in the DNA Medicine Based on DNA Modification Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the DNA Medicine Based on DNA Modification Market report?

Ans: The Applications covered in the DNA Medicine Based on DNA Modification Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the DNA Medicine Based on DNA Modification Market report?

Ans: The Types covered in the DNA Medicine Based on DNA Modification Market report are Viral, Non-viral

Recommended Reports

Gene Therapy Markets

DNA Modification Fields

CRISPR & Genetic Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Medicine Based on DNA Modification Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral
1.2.3 Non-viral
1.3 Market by Application
1.3.1 Global DNA Medicine Based on DNA Modification Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Medicine Based on DNA Modification Market Perspective (2020-2031)
2.2 Global DNA Medicine Based on DNA Modification Growth Trends by Region
2.2.1 Global DNA Medicine Based on DNA Modification Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 DNA Medicine Based on DNA Modification Historic Market Size by Region (2020-2025)
2.2.3 DNA Medicine Based on DNA Modification Forecasted Market Size by Region (2026-2031)
2.3 DNA Medicine Based on DNA Modification Market Dynamics
2.3.1 DNA Medicine Based on DNA Modification Industry Trends
2.3.2 DNA Medicine Based on DNA Modification Market Drivers
2.3.3 DNA Medicine Based on DNA Modification Market Challenges
2.3.4 DNA Medicine Based on DNA Modification Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Medicine Based on DNA Modification Players by Revenue
3.1.1 Global Top DNA Medicine Based on DNA Modification Players by Revenue (2020-2025)
3.1.2 Global DNA Medicine Based on DNA Modification Revenue Market Share by Players (2020-2025)
3.2 Global DNA Medicine Based on DNA Modification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DNA Medicine Based on DNA Modification Revenue
3.4 Global DNA Medicine Based on DNA Modification Market Concentration Ratio
3.4.1 Global DNA Medicine Based on DNA Modification Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Medicine Based on DNA Modification Revenue in 2024
3.5 Global Key Players of DNA Medicine Based on DNA Modification Head office and Area Served
3.6 Global Key Players of DNA Medicine Based on DNA Modification, Product and Application
3.7 Global Key Players of DNA Medicine Based on DNA Modification, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Medicine Based on DNA Modification Breakdown Data by Type
4.1 Global DNA Medicine Based on DNA Modification Historic Market Size by Type (2020-2025)
4.2 Global DNA Medicine Based on DNA Modification Forecasted Market Size by Type (2026-2031)
5 DNA Medicine Based on DNA Modification Breakdown Data by Application
5.1 Global DNA Medicine Based on DNA Modification Historic Market Size by Application (2020-2025)
5.2 Global DNA Medicine Based on DNA Modification Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America DNA Medicine Based on DNA Modification Market Size (2020-2031)
6.2 North America DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
6.4 North America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Medicine Based on DNA Modification Market Size (2020-2031)
7.2 Europe DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
7.4 Europe DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Medicine Based on DNA Modification Market Size (2020-2031)
8.2 Asia-Pacific DNA Medicine Based on DNA Modification Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2020-2025)
8.4 Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Medicine Based on DNA Modification Market Size (2020-2031)
9.2 Latin America DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
9.4 Latin America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Medicine Based on DNA Modification Market Size (2020-2031)
10.2 Middle East & Africa DNA Medicine Based on DNA Modification Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2020-2025)
10.4 Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen DNA Medicine Based on DNA Modification Introduction
11.1.4 Biogen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis DNA Medicine Based on DNA Modification Introduction
11.2.4 Novartis Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences DNA Medicine Based on DNA Modification Introduction
11.3.4 Gilead Sciences Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics DNA Medicine Based on DNA Modification Introduction
11.4.4 Sarepta Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen DNA Medicine Based on DNA Modification Introduction
11.6.4 Amgen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics DNA Medicine Based on DNA Modification Introduction
11.7.4 Spark Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics DNA Medicine Based on DNA Modification Introduction
11.8.4 Akcea Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.8.5 Akcea Therapeutics Recent Development
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Details
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech DNA Medicine Based on DNA Modification Introduction
11.9.4 Sunway Biotech Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.9.5 Sunway Biotech Recent Development
11.10 SIBIONO
11.10.1 SIBIONO Company Details
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO DNA Medicine Based on DNA Modification Introduction
11.10.4 SIBIONO Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.10.5 SIBIONO Recent Development
11.11 AnGes
11.11.1 AnGes Company Details
11.11.2 AnGes Business Overview
11.11.3 AnGes DNA Medicine Based on DNA Modification Introduction
11.11.4 AnGes Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.11.5 AnGes Recent Development
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics DNA Medicine Based on DNA Modification Introduction
11.12.4 Orchard Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.12.5 Orchard Therapeutics Recent Development
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Details
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute DNA Medicine Based on DNA Modification Introduction
11.13.4 Human Stem Cells Institute Revenue in DNA Medicine Based on DNA Modification Business (2020-2025)
11.13.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute
List of Tables
 Table 1. Global DNA Medicine Based on DNA Modification Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Viral
 Table 3. Key Players of Non-viral
 Table 4. Global DNA Medicine Based on DNA Modification Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global DNA Medicine Based on DNA Modification Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global DNA Medicine Based on DNA Modification Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global DNA Medicine Based on DNA Modification Market Share by Region (2020-2025)
 Table 8. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global DNA Medicine Based on DNA Modification Market Share by Region (2026-2031)
 Table 10. DNA Medicine Based on DNA Modification Market Trends
 Table 11. DNA Medicine Based on DNA Modification Market Drivers
 Table 12. DNA Medicine Based on DNA Modification Market Challenges
 Table 13. DNA Medicine Based on DNA Modification Market Restraints
 Table 14. Global DNA Medicine Based on DNA Modification Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global DNA Medicine Based on DNA Modification Market Share by Players (2020-2025)
 Table 16. Global Top DNA Medicine Based on DNA Modification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2024)
 Table 17. Ranking of Global Top DNA Medicine Based on DNA Modification Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by DNA Medicine Based on DNA Modification Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of DNA Medicine Based on DNA Modification, Headquarters and Area Served
 Table 20. Global Key Players of DNA Medicine Based on DNA Modification, Product and Application
 Table 21. Global Key Players of DNA Medicine Based on DNA Modification, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global DNA Medicine Based on DNA Modification Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global DNA Medicine Based on DNA Modification Revenue Market Share by Type (2020-2025)
 Table 25. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global DNA Medicine Based on DNA Modification Revenue Market Share by Type (2026-2031)
 Table 27. Global DNA Medicine Based on DNA Modification Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global DNA Medicine Based on DNA Modification Revenue Market Share by Application (2020-2025)
 Table 29. Global DNA Medicine Based on DNA Modification Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global DNA Medicine Based on DNA Modification Revenue Market Share by Application (2026-2031)
 Table 31. North America DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific DNA Medicine Based on DNA Modification Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific DNA Medicine Based on DNA Modification Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa DNA Medicine Based on DNA Modification Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Biogen Company Details
 Table 47. Biogen Business Overview
 Table 48. Biogen DNA Medicine Based on DNA Modification Product
 Table 49. Biogen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 50. Biogen Recent Development
 Table 51. Novartis Company Details
 Table 52. Novartis Business Overview
 Table 53. Novartis DNA Medicine Based on DNA Modification Product
 Table 54. Novartis Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 55. Novartis Recent Development
 Table 56. Gilead Sciences Company Details
 Table 57. Gilead Sciences Business Overview
 Table 58. Gilead Sciences DNA Medicine Based on DNA Modification Product
 Table 59. Gilead Sciences Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 60. Gilead Sciences Recent Development
 Table 61. Sarepta Therapeutics Company Details
 Table 62. Sarepta Therapeutics Business Overview
 Table 63. Sarepta Therapeutics DNA Medicine Based on DNA Modification Product
 Table 64. Sarepta Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 65. Sarepta Therapeutics Recent Development
 Table 66. Alnylam Pharmaceuticals Company Details
 Table 67. Alnylam Pharmaceuticals Business Overview
 Table 68. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Product
 Table 69. Alnylam Pharmaceuticals Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 70. Alnylam Pharmaceuticals Recent Development
 Table 71. Amgen Company Details
 Table 72. Amgen Business Overview
 Table 73. Amgen DNA Medicine Based on DNA Modification Product
 Table 74. Amgen Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 75. Amgen Recent Development
 Table 76. Spark Therapeutics Company Details
 Table 77. Spark Therapeutics Business Overview
 Table 78. Spark Therapeutics DNA Medicine Based on DNA Modification Product
 Table 79. Spark Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 80. Spark Therapeutics Recent Development
 Table 81. Akcea Therapeutics Company Details
 Table 82. Akcea Therapeutics Business Overview
 Table 83. Akcea Therapeutics DNA Medicine Based on DNA Modification Product
 Table 84. Akcea Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 85. Akcea Therapeutics Recent Development
 Table 86. Sunway Biotech Company Details
 Table 87. Sunway Biotech Business Overview
 Table 88. Sunway Biotech DNA Medicine Based on DNA Modification Product
 Table 89. Sunway Biotech Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 90. Sunway Biotech Recent Development
 Table 91. SIBIONO Company Details
 Table 92. SIBIONO Business Overview
 Table 93. SIBIONO DNA Medicine Based on DNA Modification Product
 Table 94. SIBIONO Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 95. SIBIONO Recent Development
 Table 96. AnGes Company Details
 Table 97. AnGes Business Overview
 Table 98. AnGes DNA Medicine Based on DNA Modification Product
 Table 99. AnGes Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 100. AnGes Recent Development
 Table 101. Orchard Therapeutics Company Details
 Table 102. Orchard Therapeutics Business Overview
 Table 103. Orchard Therapeutics DNA Medicine Based on DNA Modification Product
 Table 104. Orchard Therapeutics Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 105. Orchard Therapeutics Recent Development
 Table 106. Human Stem Cells Institute Company Details
 Table 107. Human Stem Cells Institute Business Overview
 Table 108. Human Stem Cells Institute DNA Medicine Based on DNA Modification Product
 Table 109. Human Stem Cells Institute Revenue in DNA Medicine Based on DNA Modification Business (2020-2025) & (US$ Million)
 Table 110. Human Stem Cells Institute Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. DNA Medicine Based on DNA Modification Picture
 Figure 2. Global DNA Medicine Based on DNA Modification Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DNA Medicine Based on DNA Modification Market Share by Type: 2024 VS 2031
 Figure 4. Viral Features
 Figure 5. Non-viral Features
 Figure 6. Global DNA Medicine Based on DNA Modification Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global DNA Medicine Based on DNA Modification Market Share by Application: 2024 VS 2031
 Figure 8. Neurological Diseases Case Studies
 Figure 9. Cancer Case Studies
 Figure 10. Other Case Studies
 Figure 11. DNA Medicine Based on DNA Modification Report Years Considered
 Figure 12. Global DNA Medicine Based on DNA Modification Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global DNA Medicine Based on DNA Modification Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global DNA Medicine Based on DNA Modification Market Share by Region: 2024 VS 2031
 Figure 15. Global DNA Medicine Based on DNA Modification Market Share by Players in 2024
 Figure 16. Global Top DNA Medicine Based on DNA Modification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by DNA Medicine Based on DNA Modification Revenue in 2024
 Figure 18. North America DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
 Figure 20. United States DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
 Figure 24. Germany DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific DNA Medicine Based on DNA Modification Market Share by Region (2020-2031)
 Figure 32. China DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
 Figure 40. Mexico DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa DNA Medicine Based on DNA Modification Market Share by Country (2020-2031)
 Figure 44. Turkey DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE DNA Medicine Based on DNA Modification Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Biogen Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 48. Novartis Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 49. Gilead Sciences Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 50. Sarepta Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 52. Amgen Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 53. Spark Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 54. Akcea Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 55. Sunway Biotech Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 56. SIBIONO Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 57. AnGes Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 58. Orchard Therapeutics Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 59. Human Stem Cells Institute Revenue Growth Rate in DNA Medicine Based on DNA Modification Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Advanced Therapy Based on Gene Market Research Report 2025
Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene based Advanced Therapy Medicinal Market Research Report 2025
Global Gene based Therapy Medicinal Market Research Report 2024
Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Gene Therapy Market Research Report 2025
Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapy On Cardiovascular Disease Market Research Report 2025
Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Delivery or Gene Therapy Drug Market Research Report 2025
Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Gene Therapies for Cancer Treatment Market Research Report 2024
Global Nucleic Acid Based Gene Therapy Market Research Report 2025
Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Cell and Gene Therapy Market Research Report 2024
Global Gene Therapy For Cancer Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions